Bilayer Therapeutics

Edit info

Founded: 2020

Location: Cambridge, MA

Employee range: 1 - 10

Clinical stage: Clin0

Therapy area: Chronic idiopathic constipation

Drug types: GI

Lead product: BL-010

bilayer-therapeutics.com

linkedin.com

Drug notes:

also Clin0 constipation-dominant IBD, hepatic encephalopathy; BL-020 Clin0 opioid-induced constipation; BL-030 RD UC; BL-040 RD Crohn's; BL-050 RD metabolic disorders

About:

ilayer Therapeutics, a development-stage biotech company, provides a novel approach to developing treatments for gastrointestinal disease and metabolic disorder. They were founded in 2020 by drug development and delivery experts and gastroenterologists. They hope to target the body’s innate mechanism to restore normal metabolism and motility.

Jobs:

Main

Contact: recruit@workinbiotech.com